Next Generation of CAR-T Therapies in Lymphoma
Experts comment on the future of CAR T-cell therapy development and the use of dual CAR-T and CAR-T retreatment.
Future Perspectives on CAR-T Therapies in Lymphoma
Drs Goy, Ip, and Leslie close out their discussion with a look at the exciting developments and future of CAR T-cell therapies in lymphoma treatment.
Selecting and Sequencing Therapies to Improve Outcomes in Patients With Lymphoma
Key opinion leaders describe when to refer a patient with lymphoma and at what point treatments should be switched, and the evolution of T-cell engaging therapies.
Recent Updates on CAR-T Therapies in Chronic Lymphocytic Leukemia
Dr Lori Leslie provides an overview of key clinical trial data on the use of CAR T-cell therapy in chronic lymphocytic leukemia.
Role of CAR-T Therapies in Acute Lymphoblastic Lymphoma
Drs Goy and Leslie converse on the use of CAR T-cell therapy in acute lymphoblastic lymphoma, the first approved treatment for ALL.
CAR-T Therapies in the Follicular Lymphoma Treatment Landscape
Lori Leslie, MD, explains how CAR T-cell therapy fits into follicular lymphoma treatment sequencing, highlighting data from the ZUMA-5 trial.
Brexucabtagene Autoleucel in Mantle Cell Lymphoma
Andre Goy, MD, and Andrew Ip, MD, give an overview of the approval of CAR T-cell therapy for mantle cell lymphoma treatment.
Managing Toxicities Associated with CAR-T Therapy in LBCL
Dr Andrew Ip explains the major toxicities of CAR T-cell therapy in patients with large B-cell lymphoma and how to manage them.
CAR-T therapy in Second-Line Setting in LBCL
Lymphoma physicians from John Theurer Cancer Center comment on the use of CAR T-cell therapy in large B-cell lymphoma and the implications of clinical trial data in this setting.
Selecting the Appropriate Patients and Monitoring Responses to CAR T-Cell Therapy in LBCL
Dr Lori Leslie discusses how to assess if a patient with large B-cell lymphoma is a good candidate for CAR T-cell therapy.
Clinical Trial and Real-World Evidence Around CAR T-cell Therapy in LBCL
Andrew Ip, MD, and Lori Leslie, MD, review clinical trial and real-world data on the efficacy and survival rates of CAR T-cell therapy in large B-cell lymphoma.
Game Changers in Treatment of Hematologic Malignancies
ONCOLOGY spoke to Andre Goy, MD, MS about advances on leukemia, lymphoma, and myeloma treatments.
POINT: The Role of Stem Cell Transplantation in Mantle Cell Lymphoma
The landscape of mantle cell lymphoma is clearly evolving, due to the availability of new treatment options incorporating novel biologic agents. To optimize therapy, we should build on what has been accomplished over the last 3 decades.
2 Clarke Drive Cranbury, NJ 08512